Hotline: +86-18022463983    020-85206863

Global Glucagon Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Published Date: 2025-04-23   |   Pages: 80   |   Tables: 80   |  Pharma & Healthcare

The global Glucagon market size was US$ 625 million in 2024 and is forecast to a readjusted size of US$ 941 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
The global Glucagon market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
By Type: (Dominant Segment vs High-Margin Innovation)
Inject Glucagon
Nasal Glucagon
By Application: (Core Demand Driver vs Emerging Opportunity)
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Novo Nordisk in Europe)
- Emerging Product Trends: Inject Glucagon adoption vs. Nasal Glucagon premiumization
- Demand-Side Dynamics: Emergency Kits growth in China vs. General Use potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
India
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Glucagon market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Nasal Glucagon in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., General Use in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Inject Glucagon dominance in Europe vs. Nasal Glucagon demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Market Overview
1.1 Glucagon Product Scope
1.2 Glucagon by Type
1.2.1 Global Glucagon Sales by Type (2020 & 2024 & 2031)
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Glucagon by Application
1.3.1 Global Glucagon Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Global Glucagon Market Estimates and Forecasts (2020-2031)
1.4.1 Global Glucagon Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Glucagon Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Glucagon Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Glucagon Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Glucagon Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Glucagon Sales Market Share by Region (2020-2025)
2.2.2 Global Glucagon Revenue Market Share by Region (2020-2025)
2.3 Global Glucagon Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Glucagon Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Glucagon Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Glucagon Market Size and Prospective (2020-2031)
2.4.2 Europe Glucagon Market Size and Prospective (2020-2031)
2.4.3 India Glucagon Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Glucagon Historic Market Review by Type (2020-2025)
3.1.1 Global Glucagon Sales by Type (2020-2025)
3.1.2 Global Glucagon Revenue by Type (2020-2025)
3.1.3 Global Glucagon Price by Type (2020-2025)
3.2 Global Glucagon Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Glucagon Sales Forecast by Type (2026-2031)
3.2.2 Global Glucagon Revenue Forecast by Type (2026-2031)
3.2.3 Global Glucagon Price Forecast by Type (2026-2031)
3.3 Different Types Glucagon Representative Players
4 Global Market Size by Application
4.1 Global Glucagon Historic Market Review by Application (2020-2025)
4.1.1 Global Glucagon Sales by Application (2020-2025)
4.1.2 Global Glucagon Revenue by Application (2020-2025)
4.1.3 Global Glucagon Price by Application (2020-2025)
4.2 Global Glucagon Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Glucagon Sales Forecast by Application (2026-2031)
4.2.2 Global Glucagon Revenue Forecast by Application (2026-2031)
4.2.3 Global Glucagon Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Glucagon Application
5 Competition Landscape by Players
5.1 Global Glucagon Sales by Players (2020-2025)
5.2 Global Top Glucagon Players by Revenue (2020-2025)
5.3 Global Glucagon Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon as of 2024)
5.4 Global Glucagon Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Glucagon, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Glucagon, Product Type & Application
5.7 Global Key Manufacturers of Glucagon, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Glucagon Sales by Company
6.1.1.1 North America Glucagon Sales by Company (2020-2025)
6.1.1.2 North America Glucagon Revenue by Company (2020-2025)
6.1.2 North America Glucagon Sales Breakdown by Type (2020-2025)
6.1.3 North America Glucagon Sales Breakdown by Application (2020-2025)
6.1.4 North America Glucagon Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Glucagon Sales by Company
6.2.1.1 Europe Glucagon Sales by Company (2020-2025)
6.2.1.2 Europe Glucagon Revenue by Company (2020-2025)
6.2.2 Europe Glucagon Sales Breakdown by Type (2020-2025)
6.2.3 Europe Glucagon Sales Breakdown by Application (2020-2025)
6.2.4 Europe Glucagon Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 India Market: Players, Segments, Downstream and Major Customers
6.3.1 India Glucagon Sales by Company
6.3.1.1 India Glucagon Sales by Company (2020-2025)
6.3.1.2 India Glucagon Revenue by Company (2020-2025)
6.3.2 India Glucagon Sales Breakdown by Type (2020-2025)
6.3.3 India Glucagon Sales Breakdown by Application (2020-2025)
6.3.4 India Glucagon Major Customer
6.3.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Information
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Glucagon Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Novo Nordisk Glucagon Products Offered
7.1.5 Novo Nordisk Recent Development
7.2 Eli Lilly
7.2.1 Eli Lilly Company Information
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Glucagon Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Eli Lilly Glucagon Products Offered
7.2.5 Eli Lilly Recent Development
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Company Information
7.3.2 Fresenius Kabi Business Overview
7.3.3 Fresenius Kabi Glucagon Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Fresenius Kabi Glucagon Products Offered
7.3.5 Fresenius Kabi Recent Development
7.4 Torrent Labs
7.4.1 Torrent Labs Company Information
7.4.2 Torrent Labs Business Overview
7.4.3 Torrent Labs Glucagon Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Torrent Labs Glucagon Products Offered
7.4.5 Torrent Labs Recent Development
7.5 Taj Pharmaceuticals
7.5.1 Taj Pharmaceuticals Company Information
7.5.2 Taj Pharmaceuticals Business Overview
7.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Taj Pharmaceuticals Glucagon Products Offered
7.5.5 Taj Pharmaceuticals Recent Development
7.6 Xeris Pharmaceuticals
7.6.1 Xeris Pharmaceuticals Company Information
7.6.2 Xeris Pharmaceuticals Business Overview
7.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Xeris Pharmaceuticals Glucagon Products Offered
7.6.5 Xeris Pharmaceuticals Recent Development
8 Glucagon Manufacturing Cost Analysis
8.1 Glucagon Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Glucagon
8.4 Glucagon Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Glucagon Distributors List
9.3 Glucagon Customers
10 Glucagon Market Dynamics
10.1 Glucagon Industry Trends
10.2 Glucagon Market Drivers
10.3 Glucagon Market Challenges
10.4 Glucagon Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer

List of Tables
Table 1. Global Glucagon Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Glucagon Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Glucagon Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Glucagon Sales (K MT) by Region (2020-2025)
Table 5. Global Glucagon Sales Market Share by Region (2020-2025)
Table 6. Global Glucagon Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Glucagon Revenue Share by Region (2020-2025)
Table 8. Global Glucagon Sales (K MT) Forecast by Region (2026-2031)
Table 9. Global Glucagon Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Glucagon Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Glucagon Revenue Share Forecast by Region (2026-2031)
Table 12. Global Glucagon Sales by Type (K MT) & (2020-2025)
Table 13. Global Glucagon Sales Share by Type (2020-2025)
Table 14. Global Glucagon Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Glucagon Price by Type (USD/MT) & (2020-2025)
Table 16. Global Glucagon Sales by Type (K MT) & (2026-2031)
Table 17. Global Glucagon Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Glucagon Price by Type (USD/MT) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Glucagon Sales by Application (K MT) & (2020-2025)
Table 21. Global Glucagon Sales Share by Application (2020-2025)
Table 22. Global Glucagon Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Glucagon Price by Application (USD/MT) & (2020-2025)
Table 24. Global Glucagon Sales by Application (K MT) & (2026-2031)
Table 25. Global Glucagon Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Glucagon Price by Application (USD/MT) & (2026-2031)
Table 27. New Sources of Growth in Glucagon Application
Table 28. Global Glucagon Sales by Company (K MT) & (2020-2025)
Table 29. Global Glucagon Sales Share by Company (2020-2025)
Table 30. Global Glucagon Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Glucagon Revenue Share by Company (2020-2025)
Table 32. Global Glucagon by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon as of 2024)
Table 33. Global Market Glucagon Average Price by Company (USD/MT) & (2020-2025)
Table 34. Global Key Manufacturers of Glucagon, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Glucagon, Product Type & Application
Table 36. Global Key Manufacturers of Glucagon, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Glucagon Sales by Company (2020-2025) & (K MT)
Table 39. North America Glucagon Sales Market Share by Company (2020-2025)
Table 40. North America Glucagon Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Glucagon Revenue Market Share by Company (2020-2025)
Table 42. North America Glucagon Sales by Type (2020-2025) & (K MT)
Table 43. North America Glucagon Sales Market Share by Type (2020-2025)
Table 44. North America Glucagon Sales by Application (2020-2025) & (K MT)
Table 45. North America Glucagon Sales Market Share by Application (2020-2025)
Table 46. Europe Glucagon Sales by Company (2020-2025) & (K MT)
Table 47. Europe Glucagon Sales Market Share by Company (2020-2025)
Table 48. Europe Glucagon Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Glucagon Revenue Market Share by Company (2020-2025)
Table 50. Europe Glucagon Sales by Type (2020-2025) & (K MT)
Table 51. Europe Glucagon Sales Market Share by Type (2020-2025)
Table 52. Europe Glucagon Sales by Application (2020-2025) & (K MT)
Table 53. Europe Glucagon Sales Market Share by Application (2020-2025)
Table 54. India Glucagon Sales by Company (2020-2025) & (K MT)
Table 55. India Glucagon Sales Market Share by Company (2020-2025)
Table 56. India Glucagon Revenue by Company (2020-2025) & (US$ Million)
Table 57. India Glucagon Revenue Market Share by Company (2020-2025)
Table 58. India Glucagon Sales by Type (2020-2025) & (K MT)
Table 59. India Glucagon Sales Market Share by Type (2020-2025)
Table 60. India Glucagon Sales by Application (2020-2025) & (K MT)
Table 61. India Glucagon Sales Market Share by Application (2020-2025)
Table 62. Novo Nordisk Company Information
Table 63. Novo Nordisk Description and Business Overview
Table 64. Novo Nordisk Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 65. Novo Nordisk Glucagon Product
Table 66. Novo Nordisk Recent Development
Table 67. Eli Lilly Company Information
Table 68. Eli Lilly Description and Business Overview
Table 69. Eli Lilly Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 70. Eli Lilly Glucagon Product
Table 71. Eli Lilly Recent Development
Table 72. Fresenius Kabi Company Information
Table 73. Fresenius Kabi Description and Business Overview
Table 74. Fresenius Kabi Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Fresenius Kabi Glucagon Product
Table 76. Fresenius Kabi Recent Development
Table 77. Torrent Labs Company Information
Table 78. Torrent Labs Description and Business Overview
Table 79. Torrent Labs Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Torrent Labs Glucagon Product
Table 81. Torrent Labs Recent Development
Table 82. Taj Pharmaceuticals Company Information
Table 83. Taj Pharmaceuticals Description and Business Overview
Table 84. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Taj Pharmaceuticals Glucagon Product
Table 86. Taj Pharmaceuticals Recent Development
Table 87. Xeris Pharmaceuticals Company Information
Table 88. Xeris Pharmaceuticals Description and Business Overview
Table 89. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Xeris Pharmaceuticals Glucagon Product
Table 91. Xeris Pharmaceuticals Recent Development
Table 92. Production Base and Market Concentration Rate of Raw Material
Table 93. Key Suppliers of Raw Materials
Table 94. Glucagon Distributors List
Table 95. Glucagon Customers List
Table 96. Glucagon Market Trends
Table 97. Glucagon Market Drivers
Table 98. Glucagon Market Challenges
Table 99. Glucagon Market Restraints
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources


List of Figures
Figure 1. Glucagon Product Picture
Figure 2. Global Glucagon Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Glucagon Sales Market Share by Type in 2024 & 2031
Figure 4. Inject Glucagon Product Picture
Figure 5. Nasal Glucagon Product Picture
Figure 6. Global Glucagon Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Glucagon Sales Market Share by Application in 2024 & 2031
Figure 8. Emergency Kits Examples
Figure 9. General Use Examples
Figure 10. Diagnostic & Motility Examples
Figure 11. Cardiogenic Shock Examples
Figure 12. Others Examples
Figure 13. Global Glucagon Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Glucagon Sales Growth Rate (2020-2031) & (US$ Million)
Figure 15. Global Glucagon Sales (K MT) Growth Rate (2020-2031)
Figure 16. Global Glucagon Price Trends Growth Rate (2020-2031) & (USD/MT)
Figure 17. Glucagon Report Years Considered
Figure 18. Global Market Glucagon Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 19. Global Glucagon Revenue Market Share by Region: 2020 VS 2024
Figure 20. North America Glucagon Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. North America Glucagon Sales (K MT) Growth Rate (2020-2031)
Figure 22. Europe Glucagon Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Europe Glucagon Sales (K MT) Growth Rate (2020-2031)
Figure 24. India Glucagon Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. India Glucagon Sales (K MT) Growth Rate (2020-2031)
Figure 26. Global Glucagon Revenue Share by Type (2020-2025)
Figure 27. Global Glucagon Sales Share by Type (2026-2031)
Figure 28. Global Glucagon Revenue Share by Type (2026-2031)
Figure 29. Global Glucagon Revenue Share by Application (2020-2025)
Figure 30. Global Glucagon Revenue Growth Rate by Application in 2020 & 2024
Figure 31. Global Glucagon Sales Share by Application (2026-2031)
Figure 32. Global Glucagon Revenue Share by Application (2026-2031)
Figure 33. Global Glucagon Sales Share by Company (2024)
Figure 34. Global Glucagon Revenue Share by Company (2024)
Figure 35. Global 5 Largest Glucagon Players Market Share by Revenue in Glucagon: 2020 & 2024
Figure 36. Glucagon Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 37. Manufacturing Cost Structure of Glucagon
Figure 38. Manufacturing Process Analysis of Glucagon
Figure 39. Glucagon Industrial Chain
Figure 40. Channels of Distribution (Direct Vs Distribution)
Figure 41. Distributors Profiles
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed

Our Clients